Concepedia

Vasiliki Michalarea

VM

13

Publications

512

Citations

12

H-Index

2012

Active since

Affiliations

Institute of Cancer Research(Current)

Royal Marsden Hospital

University College London

Royal Marsden NHS Foundation Trust

University College Hospital

Vasiliki Michalarea is an author at Institute of Cancer Research specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2012–2022

13

Publications

13

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with <i>BRCA1/2</i> - and Non– <i>BRCA1/2</i> -Mutant Cancers

Timothy A. Yap, Rebecca Kristeleit, Vasiliki Michalarea et al. · Cancer Discovery · 2020 · 130 citations · Full text

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

Michael Kolinsky, Pasquale Rescigno, Diletta Bianchini et al. · Annals of Oncology · 2020 · 85 citations · Full text

The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials

Rajiv Kumar, Elena Geuna, Vasiliki Michalarea et al. · British Journal of Cancer · 2015 · 80 citations · Full text

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Johann S. de Bono, Chia‐Chi Lin, Li‐Tzong Chen et al. · British Journal of Cancer · 2020 · 40 citations · Full text

Modulation of Biliary Cancer Chemo‐Resistance Through MicroRNA‐Mediated Rewiring of the Expansion of CD133+ Cells

Pietro Carotenuto, Somaieh Hedayat, Matteo Fassan et al. · Hepatology · 2019 · 39 citations · Full text

Rows per page

1–5 of 13